Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06823297Not Yet Recruiting

Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

Role: lead

NCT06902701Not Yet Recruiting

Endoscopic Submucosal Dissection vs. Transanal Endoscopic Surgery for Rectal Neoplasia

Role: lead

NCT06984601Not Yet Recruiting

RELIEF Study: Resolving Fissures With Lateral Internal Sphincterotomy

Role: lead

NCT06971107Not Yet Recruiting

Current Microsatellite Stability Results in Colon Cancer

Role: lead

All 4 trials loaded